48 results on '"Kimber, Thomas"'
Search Results
2. Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
3. An Interview with Dr. Kimber Thomas, Senior Innovation Specialist with the Connecting Communities Digital Initiative (CCDI) at the Library of Congress
4. Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson’s Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
5. Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
6. Quality of Life Effects of Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa in People with Parkinson’s (P9-3.003)
7. Improvement of “On” and “Off” Times in Patients with Advanced Parkinson’s Disease Treated with Foslevodopa/Foscarbidopa: Subgroup Analyses from a Phase 3 Randomized Study (S30.007)
8. Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
9. Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial
10. 2618 A phase 2 randomised controlled trial of sodium selenate as a disease-modifying treatment for probable progressive supranuclear palsy
11. Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
12. Isn’t a Call Enough? What Is the Purpose of Psychologically Assessing Cross-Cultural Mission Workers?
13. Characterizing a Parkinson’s Disease Population Inadequately Controlled by Oral Therapy: Baseline Characteristics of the Phase 3 Clinical Program for Foslevodopa/Foscarbidopa (P2-11.006)
14. Safety of Foslevodopa/Foscarbidopa During Optimization and Maintenance Treatment: Post Hoc Analysis of a Phase 3 Trial (S32.004)
15. Psychological Assessment of Cross-Cultural Mission Candidates in Australasia
16. Brainstem lesions and gait
17. A Scoping Review of Psychological Assessment in Mission and Ministry Candidates
18. Practical approaches to commencing device‐assisted therapies for Parkinson disease in Australia
19. Ibrutinib monotherapy as effective treatment of central nervous system involvement by chronic lymphocytic leukaemia
20. Makeshifting: Black Women and Resilient Creativity in the Rural South
21. Driving restrictions following deep brain stimulation surgery
22. Sodium selenate as a disease-modifying treatment for progressive supranuclear palsy: protocol for a phase 2, randomised, double-blind, placebo-controlled trial
23. Review: Against All Odds
24. 060 A case report of myelin oligodendrocyte glycoprotein antibody positive encephalitis mimicking HaNDL syndrome with subsequent acute optic neuritis
25. A Scoping Review of Psychological Assessment in Mission and Ministry Candidates
26. The Color Purple
27. Approach to the patient with early Parkinson disease: diagnosis and management
28. Book Review: Liturgy of the Ordinary: Sacred Practices in Everyday Life
29. Benefits of Levodopa-Carbidopa Intestinal Gel Infusion in Patients with Parkinson’s Disease Experiencing Gait Dysfunction Following Subthalamic Deep Brain Stimulation
30. Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data
31. Progressive cranial neuropathy and uterine involvement in myeloid sarcoma
32. Updates and advances in the treatment of Parkinson disease
33. A blinded, controlled trial of objective measurement in Parkinson's disease.
34. Book Review: Reading Your Life’s Story: An Invitation to Spiritual Mentoring
35. Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
36. Long-term adherence to apomorphine infusion in patients with Parkinson disease: a 10-year observational study
37. Pantoprazole-induced hypomagnesaemia causing cerebellar syndrome and seizures
38. 1. Fashion victim: Rhabdomyolysis and bilateral peroneal and tibial neuropathies as a result of squatting in skinny jeans
39. Ibrutinib monotherapy as effective treatment of central nervous system involvement by chronic lymphocytic leukaemia
40. Gastric emptying, postprandial blood pressure, glycaemia and splanchnic flow in Parkinson’s disease
41. Dystonia‐Parkinsonism Due to Pallidal and Nigral Necrosis Following Heroin Overdose: Long‐Term Evolution
42. Fashion victim: rhabdomyolysis and bilateral peroneal and tibial neuropathies as a result of squatting in ‘skinny jeans’
43. Su1503 Direct Endoscopic Jejunostomy for the Administration of Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease
44. Segmental Dystonia in the Context of Dextromethorphan Abuse: A New Cause of Delayed Onset Drug-Induced Dystonia?
45. Dystonia-Parkinsonism Due to Pallidal and Nigral Necrosis Following Heroin Overdose: Long-Term Evolution.
46. Fashion victim: rhabdomyolysis and bilateral peroneal and tibial neuropathies as a result of squatting in 'skinny jeans'.
47. Electroconvulsive therapy for the neurological and psychiatric manifestations of multiple system atrophy.
48. Reading Your Life’s Story: An Invitation to Spiritual Mentoring.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.